Literature DB >> 11076250

Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

B Khoshnood1, P Pryde, S Wall, J Singh, R Mittendorf, K S Lee.   

Abstract

OBJECTIVES: This study explored whether ethnic differences in the impact of advanced maternal age on the risk of Down syndrome might reflect differences in use of prenatal diagnostic technologies.
METHODS: Maternal age-specific odds of Down syndrome and amniocentesis use were compared among African Americans, Mexican Americans, and non-Hispanic Whites via birth data for the years 1989 to 1991.
RESULTS: The odds ratio and population attributable risk of Down syndrome due to maternal age of 35 years or older were highest for Mexican Americans, intermediate for African Americans, and lowest for non-Hispanic Whites.
CONCLUSIONS: Advanced maternal age has a greater impact on the risk of Down syndrome for African American and, particularly, Mexican American women than for non-Hispanic White women. This difference in impact might reflect lower availability or use of prenatal diagnostic technologies.

Entities:  

Mesh:

Year:  2000        PMID: 11076250      PMCID: PMC1446403          DOI: 10.2105/ajph.90.11.1778

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Prenatal screening for Down's syndrome with use of maternal serum markers.

Authors:  J E Haddow; G E Palomaki; G J Knight; J Williams; A Pulkkinen; J A Canick; D N Saller; G B Bowers
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

2.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

3.  Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991.

Authors:  J Bishop; C A Huether; C Torfs; F Lorey; J Deddens
Journal:  Am J Epidemiol       Date:  1997-01-15       Impact factor: 4.897

Review 4.  Conceptual problems in the definition and interpretation of attributable fractions.

Authors:  S Greenland; J M Robins
Journal:  Am J Epidemiol       Date:  1988-12       Impact factor: 4.897

Review 5.  The second-trimester fetus with Down syndrome: detection using sonographic features.

Authors:  B R Benacerraf
Journal:  Ultrasound Obstet Gynecol       Date:  1996-02       Impact factor: 7.299

6.  Maternal age-specific rates for Down syndrome: changes over time.

Authors:  P A Baird; A D Sadovnick
Journal:  Am J Med Genet       Date:  1988-04

Review 7.  Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.

Authors:  P G Pryde; A Drugan; M P Johnson; N B Isada; M I Evans
Journal:  Clin Obstet Gynecol       Date:  1993-09       Impact factor: 2.190

8.  Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.

Authors:  P A Benn; J M Clive; R Collins
Journal:  Clin Chem       Date:  1997-02       Impact factor: 8.327

9.  Parental decision following prenatal diagnosis of fetal chromosome abnormality.

Authors:  M S Verp; A T Bombard; J L Simpson; S Elias
Journal:  Am J Med Genet       Date:  1988-03

10.  Trends and variations in first births to older women, United States, 1970-86.

Authors:  S J Ventura
Journal:  Vital Health Stat 21       Date:  1989-06
View more
  10 in total

1.  Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for down syndrome: results of the French National Perinatal Survey of 1998.

Authors:  Babak Khoshnood; Béatrice Blondel; Catherine de Vigan; Gérard Bréart
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

2.  Advances in medical technology and creation of disparities: the case of Down syndrome.

Authors:  Babak Khoshnood; Catherine De Vigan; Véronique Vodovar; Gérard Bréart; François Goffinet; Béatrice Blondel
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

3.  Live births, natural losses, and elective terminations with Down syndrome in Massachusetts.

Authors:  Gert de Graaf; Frank Buckley; Brian G Skotko
Journal:  Genet Med       Date:  2016-04-14       Impact factor: 8.822

4.  Possible risk factors for Down syndrome and sex chromosomal aneuploidy in Mysore, South India.

Authors:  Suttur S Malini; Nallur B Ramachandra
Journal:  Indian J Hum Genet       Date:  2007-09

5.  Chromosomal disorders: estimating baseline birth prevalence and pregnancy outcomes worldwide.

Authors:  Sowmiya Moorthie; Hannah Blencowe; Matthew W Darlison; Stephen Gibbons; Joy E Lawn; Pierpaolo Mastroiacovo; Joan K Morris; Bernadette Modell
Journal:  J Community Genet       Date:  2017-09-26

6.  Potential Increased Risk of Trisomy 18 Observed After a Fertilizer Warehouse Fire in Brazos County and TX.

Authors:  Xiaohui Xu; Xiao Zhang; JeongWon Han; Yau Adamu; Bangning Zhang
Journal:  Int J Environ Res Public Health       Date:  2020-04-08       Impact factor: 3.390

7.  Incidence of Down Syndrome by maternal age in Chinese population.

Authors:  Yi Song; Song Jieping; Zhou Tianshu; Zhang Zhijun; Zhang Jingxuan; Wang Bo
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

8.  Down syndrome in tribal population in India: A field observation.

Authors:  Ram Lakhan; Madhavaram Thomas Kishore
Journal:  J Neurosci Rural Pract       Date:  2016 Jan-Mar

9.  Assessing sociodemographic differences (or lack thereof) in prenatal diagnosis of congenital heart defects: a population-based study.

Authors:  Babak Khoshnood; Nathalie Lelong; Thibaut Andrieu; Lucile Houyel; Damien Bonnet; Jean-Marie Jouannic; François Goffinet
Journal:  BMJ Open       Date:  2016-03-23       Impact factor: 2.692

10.  Architecture of population-differentiated polymorphisms in the human genome.

Authors:  Maulana Bachtiar; Yu Jin; Jingbo Wang; Tin Wee Tan; Samuel S Chong; Kenneth H K Ban; Caroline G L Lee
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.